ArticleFrontiers in neurology2026
The dual role of APOE ε4 allele in cerebral small vessel disease: independent genetic effects and effect modification of traditional risk factors.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The association between apolipoprotein E (APOE) ε4 and cerebral small vessel disease (CSVD) remains incompletely understood, with inconsistent evidence across imaging phenotypes and limited investigation into gene-environment interactions. Method: This cross-sectional study included 728 patients with chronic lacunar infarcts who underwent 3 T brain MRI. CSVD burden was quantified using a study-specific composite score (range 0-6), integrating white matter hyperintensities (WMH), cerebral microbleeds (CMBs), and enlarged perivascular spaces (EPVS). APOE ε4 carriers (n = 139) were compared with non-carriers (n = 589). Ordinal logistic regression and Firth's penalized logistic regression (for EPVS) were used to assess the independent effect of APOE ε4 on CSVD markers. Multiplicative interaction terms (APOE ε4 × smoking, APOE ε4 × alcohol use) were added to the fully adjusted models, with Results: APOE ε4 was independently associated only with periventricular WMH burden ( Conclusion: APOE ε4 exhibits both an independent genetic effect-selectively associated with periventricular white matter injury-and a modifying effect on the associations of smoking and alcohol use with specific CSVD phenotypes. These findings highlight the phenotypic specificity of APOE ε4's dual role in CSVD and support the integration of genetic background with modifiable risk factors for precision risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.